Mesenchymal stem/stromal cells (MSCs) are a promising resource for cell-based therapy
because of their high immunomodulation ability, tropism towards inflamed and injured …

Stem cells including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs)
and adult stem cells (ASCs) are able to repair/replace damaged or degenerative tissues and …

Mesenchymal stem cells (MSCs) are self-renewable cells capable for multilineage
differentiation and immunomodulation. MSCs are able to differentiate into all cell types of …

Aims: Hypoxic-ischaemic encephalopathy (HIE) is one of the most serious complications in
neonates and infants. Mesenchymal stromal cell (MSC)-based therapy is emerging as a …

It is well acknowledged that neuroprotective effects of transplanted mesenchymal stem cells
(MSCs) in ischemic stroke are attributed to their paracrine-mediated actions or bystander …

Background Neuroinflammation often develops in sepsis leading to activation of cerebral
endothelium, increased permeability of the blood-brain barrier (BBB), and neutrophil …

Due to their characteristics, mesenchymal stem cells (MSCs) are considered a potential
therapy for brain tissue injury or degeneration. Nevertheless, despite the promising results …

It has been reported that the therapeutic potential of stem cells is mainly mediated by their
paracrine factors. In order to identify the effects of conditioned medium of mesenchymal stem …

Despite recent advances in neurosurgery and pharmaceuticals, contemporary treatments
are ineffective in restoring lost neurological functions in patients with injuries and disorders …

Administration of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) is
believed to be an effective method for treating neurodevelopmental disorders. In this study …